JPRN-UMIN000034502已完成未知
An ancillary study of 'Investigation of efficacy of nivolumab in patients with recurrent and refractory peripheral T cell lymphoma: Investigator initiated phase 2 clinical trial' - W-JHS NHL02-A study
Cooperative study between the West Japan Hematology Study Group and Clinical Research Support Center Kyushu0 个研究点目标入组 20 人开始时间: 2018年10月15日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Nothing particular
研究者
相似试验
进行中（未招募）
不适用
W-JHS NHL02-A studyPeripheral T-cell lymphoma (including extranodal NK/T-cell lymphoma)JPRN-jRCT1071210120Akashi Koichi20
已完成
不适用
A retrospective study to explore the efficacy and safety of FOLFOX therapy and FOLFOX with radiation in esophageal squamous cell carcinomaesophageal squamous cell carcinomaJPRN-UMIN000047501ational Hospital Organization Nagoya Medical Center, Department of Medical Oncology143
已完成
3 期
A Follow-up Study of the Efficacy of a Complementary Medicine Formulation in Primary HypercholesterolemiaPrimary hypercholesteremiaDiet and Nutrition - Other diet and nutrition disordersACTRN12605000257662Pathways30
进行中（未招募）
2 期
A prospective study of investigating the efficacy of FOLFIRI plus Aflibercept as a 2nd line therapy after progression during FOLFOXIRI plus Bevacizumab in unrescetable / metastatic colorectal cancer (CRC) patients.Colorectal CancerJPRN-jRCTs071190003Oki Eiji35
招募中
不适用
on-interventional study for the analysis of efficacy and safety of EstraCept(R) 280 mg (Estramustin phosphate) at patients with castration resistant prostate cancer in three therapy situationsC61Malignant neoplasm of prostateDRKS00003204PharmaCept GmbH300